EVs delivery of miR-1915-3p improves the chemotherapeutic efficacy of oxaliplatin in colorectal cancer

被引：0
|
作者：
Zhenhuan Xiao
Yun Liu
Qun Li
Qinyuan Liu
Yong Liu
Yan Luo
Songzhi Wei
机构：
[1] The Shenzhen Hospital of Southern Medical University,Department of General Surgery
[2] The First Affiliated Hospital of Nanchang University,Department of Pediatrics
[3] The Shenzhen Hospital of Southern Medical University,Health Management Center
[4] The People’s Hospital of Leping City,Department of Oncology
[5] The Third Affiliated Hospital of Nanchang University,Department of Oncology
[6] The Third Hospital of Nanchang,Department of Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2021年 / 88卷
关键词：
Colorectal cancer; Chemoresistance; Chemosensitivity; Oxaliplatin; miR-1915-3p;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1021 / 1031
页数：10
相关论文
共 50 条
  • [41] Metastatic colorectal cancer chemotherapeutic drugs alter the expression of TGFβ signaling-related miR-175p, miR-21-5p and miR-93-5p in vitro
    Despotovic, J.
    Nikolic, A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1581 - 1582
  • [42] miR-148-3p:mdfic Pathway Improves the Efficacy of Therapeutic Cardiac Reprogramming
    Sun, Hualing
    Pratt, Richard E.
    Dzau, Victor
    Hodgkinson, Conrad
    CIRCULATION, 2022, 146
  • [43] miR-187-5p and miR-219a-1-3p: potential biomarkers associated with chemotherapeutic response and prognosis in ovarian cancer
    Huang, Chia-Yen
    Huang, Hsien-Da
    CANCER RESEARCH, 2017, 77
  • [44] circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637
    Zhang, Yanli
    Li, Chen
    Liu, Xinfeng
    Wang, Yanlei
    Zhao, Rui
    Yang, Yongmei
    Zheng, Xin
    Zhang, Yi
    Zhang, Xin
    EBIOMEDICINE, 2019, 48 : 277 - 288
  • [45] LncRNA BCAR4 promotes oxaliplatin resistance in colorectal cancer by modulating miR-484-3p/RAB5C expression
    Li, Xianting
    Chen, Xiaojiao
    Fu, Chendong
    Xie, Ming
    Ouyang, Shurui
    CHEMOTHERAPY, 2023, 68 (03) : 119 - 130
  • [46] XPF-ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer
    Huang, Ming-Yii
    Huang, Yi-Jung
    Cheng, Tian-Lu
    Jhang, Wun-Ya
    Ke, Chien-Chih
    Chen, Yi-Ting
    Kuo, Shih-Hsun
    Lin, I-Ling
    Huang, Yu-Hsiang
    Chuang, Chih-Hung
    CELLS, 2023, 12 (11)
  • [47] The effectiveness of plasma miR-33a-5p as a predictive biomarker for the efficacy of colorectal cancer chemotherapy
    Sasaki, Megumi
    Ishikawa, Toshiaki
    Ishiguro, Megumi
    Okazaki, Satoshi
    Yamauchi, Shinichi
    Kikuchi, Akifumi
    Matsuyama, Takatoshi
    Kawada, Kenro
    Tokunaga, Masanori
    Uetake, Hiroyuki
    Kinugasa, Yusuke
    ONCOLOGY LETTERS, 2021, 21 (06)
  • [48] MiR-29a-3p: a potential biomarker and therapeutic target in colorectal cancer
    Wen-Yan Mo
    Shi-Qiong Cao
    Clinical and Translational Oncology, 2023, 25 : 563 - 577
  • [49] Different miR-21-3p isoforms and their different features in colorectal cancer
    Jiao, Weijuan
    Leng, Xueqin
    Zhou, Qun
    Wu, Yayun
    Sun, Lina
    Tan, Yan
    Ni, Hengli
    Dong, Xiaoqiang
    Shen, Tong
    Liu, Yao
    Li, Jianming
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (10) : 2103 - 2111
  • [50] Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer
    Nonaka, Ryoji
    Nishimura, Junichi
    Kagawa, Yoshinori
    Osawa, Hideki
    Hasegawa, Junichi
    Murata, Kohei
    Okamura, Shu
    Ota, Hirofumi
    Uemura, Mamoru
    Hata, Taishi
    Takemasa, Ichiro
    Mizushima, Tsunekazu
    Okuzaki, Daisuke
    Yamamoto, Hirofumi
    Doki, Yuichiro
    Mori, Masaki
    ONCOLOGY REPORTS, 2014, 32 (06) : 2354 - 2358
12345